NCT04987268View on ClinicalTrials.gov

CHIP and Residual Cardiovascular Event Tendency After Smoking Cessation

CompletedOBSERVATIONAL
Enrollment

1,029

Participants

Timeline

Start Date

August 20, 2021

Primary Completion Date

August 20, 2022

Study Completion Date

August 20, 2023

Conditions
ACSClonal Hematopoiesis of Indeterminate PotentialSmoking Cessation
Interventions
GENETIC

clonal hematopoiesis of indeterminate potential

Whole-exome sequencing is performed to detect the presence of clonal hematopoiesis of indeterminate potential (CHIP)

Trial Locations (1)

110016

General Hospital of Shenyang Military Region, Shenyang

All Listed Sponsors
lead

Shenyang Northern Hospital

OTHER

NCT04987268 - CHIP and Residual Cardiovascular Event Tendency After Smoking Cessation | Biotech Hunter | Biotech Hunter